Key takeaway
In 359 Dutch adults, those with current depression or anxiety moved less on 14-day actigraphy (moderate-to-vigorous activity 35.32 vs 47.64 min/day, p = .023) than people with no diagnosis, yet their measured sleep did not differ. This is a cross-sectional comparison in a modest sample, so it cannot show whether low activity causes or results from the disorders.
Study design
Research article
Reading basis
Published abstract
Reading focus
Design & applicability
The research question
Sleep problems and low activity are common in depression and anxiety, but most evidence relies on questionnaires. The authors asked whether objective wrist-worn actigraphy shows different sleep, daily rhythm and activity in people with current, remitted or no depression or anxiety, and whether questionnaires tell the same story.
Who and how
Analysis of 14-day actigraphy data from 359 participants in the Netherlands Study of Depression and Anxiety: 93 with current, 176 with remitted and 90 with no composite international diagnostic interview depression or anxiety diagnosis. Objective estimates were sleep duration, sleep efficiency, relative amplitude (RA) between day-time and night-time activity, mid sleep on free days, gross motor activity (GMA) and moderate-to-vigorous physical activity (MVPA). Self-reported measures included an insomnia rating scale, sleep duration, mid sleep on free days, metabolic equivalent total and MVPA. The abstract does not report the statistical adjustments used.
What it found
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Compared with controls, people with current depression or anxiety had lower objective activity: GMA 23.83 vs 27.4 milli-gravity/day (p = .022) and MVPA 35.32 vs 47.64 min/day (p = .023). Self-reported activity did not differ.
- 2Their day-night rhythm was slightly weaker: relative amplitude 0.82 vs 0.83 (p = .033), again visible only in the objective data.
- 3Sleep showed the opposite pattern. People with current disorders reported both shorter and longer sleep and more insomnia, but actigraphy-measured sleep did not differ from people without current disorders.
- 4More symptoms and more diagnoses were associated with larger disturbances in the actigraphy measures.
Limits & uncertainty
- 1With 93 people in the current-disorder group and 359 overall, the study is small, and the tiny relative amplitude gap (0.82 vs 0.83) may have little practical meaning.
- 2One snapshot cannot show direction: low activity could be a result of the illness, a contributor, or both.
- 3Wrist actigraphy estimates sleep from movement and can misclassify quiet wakefulness, which may partly explain why it disagreed with self-reports.
- 4This reading rests on the abstract only.
What to take from it
The study suggests how people feel they sleep and how much they actually move can tell different stories, and each adds information. Low movement and a flattened day-night routine tend to travel with depression or anxiety, but this does not show that increasing activity treats either condition. Concerns about mood or sleep belong with a clinician.
Reading your own data
A wrist wearable gives actigraphy-like data: daily movement, active minutes and sleep timing. Compare your own weeks on the same device and look at trends in activity and in how regular your sleep and wake times are, alongside how you feel, instead of relying on one night's score.
How to read this evidence
The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.
Authors’ structured abstract English
The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.
Background
Actigraphy may provide a more valid assessment of sleep, circadian rhythm (CR), and physical activity (PA) than self-reported questionnaires, but has not been used widely to study the association with depression/anxiety and their clinical characteristics.
Methods
Fourteen-day actigraphy data of 359 participants with current (n = 93), remitted (n = 176), or no (n = 90) composite international diagnostic interview depression/anxiety diagnoses were obtained from the Netherlands Study of Depression and Anxiety. Objective estimates included sleep duration (SD), sleep efficiency, relative amplitude (RA) between day-time and night-time activity, mid sleep on free days (MSF), gross motor activity (GMA), and moderate-to-vigorous PA (MVPA). Self-reported measures included insomnia rating scale, SD, MSF, metabolic equivalent total, and MVPA.
Results
Compared to controls, individuals with current depression/anxiety had a significantly different objective, but not self-reported, PA and CR: lower GMA (23.83 vs. 27.4 milli-gravity/day, p = .022), lower MVPA (35.32 vs. 47.64 min/day, p = .023), lower RA (0.82 vs. 0.83, p = .033). In contrast, self-reported, but not objective, sleep differed between people with current depression/anxiety compared to those without current disorders; people with current depression/anxiety reported both shorter and longer SD and more insomnia. More depressive/anxiety symptoms and number of depressive/anxiety diagnoses were associated with larger disturbances of the actigraphy measures.
Conclusion
Actigraphy provides ecologically valid information on sleep, CR, and PA that enhances data from self-reported questionnaires. As those with more severe or comorbid forms showed the lowest PA and most CR disruptions, the potential for adjunctive behavioral and chronotherapy interventions should be explored, as well as the potential of actigraphy to monitor treatment response to such interventions.
Sources & attribution
Sleep, circadian rhythm, and physical activity patterns in depressive and anxiety disorders: A 2-week ambulatory assessment study.
Difrancesco S, Lamers F, Riese H, Merikangas KR, Beekman ATF, van Hemert AM, Schoevers RA, Penninx BWJH.
Depression and anxiety · 2019-07-26
DOI: 10.1002/da.22949 ↗PubMed · 31348850 ↗Europe PMC · Recorded licence: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
MoveVitals editorial interpretation · educational content · no individual clinical review recorded
Sources checked 2026-11-01
Practical guides
Read in context
7,000 steps a day linked to lower risk of death, heart disease and dementia than 2,000
Compared with 2000 steps a day, 7000 steps was associated with a hazard ratio of 0.53 (95% CI 0.46 to 0.60) for all-cause mortality across 14 studies, 0.75 (0.67 to 0.85) for cardiovascular disease and 0.62 (0.53 to 0.73) for dementia; cancer incidence was not significantly different (0.94, 0.87 to 1.01). Several outcomes rest on only two to four studies, and the certainty of evidence ranged from moderate to very low.
The Lancet Public Health
Brief bursts of vigorous effort in daily life linked to lower mortality in non-exercisers
Among 25,241 UK Biobank adults who reported no leisure-time exercise, a median of 3 vigorous bouts of 1 or 2 minutes a day, picked up by a wrist accelerometer, was associated with a 38% to 40% lower risk of all-cause and cancer death and a 48% to 49% lower risk of cardiovascular death than no such bouts, over an average of 6.9 years and 852 deaths. This is an observational study using one week of wrist data and an algorithm to define vigorous effort, so it cannot show that adding such bursts causes the lower risk.
Nature Medicine
Steps and mortality: gains flatten near 6,000–8,000 (age 60+) and 8,000–10,000 (under 60)
Pooling 15 cohorts (47,471 adults, 3,013 deaths, median follow-up 7.1 years), the second, third and fourth quartiles of daily steps (medians 5,801, 7,842 and 10,901) had hazard ratios for death of 0.60, 0.55 and 0.47 against the lowest quartile (median 3,553). The curve flattened at about 6,000 to 8,000 steps a day for adults aged 60 and over and 8,000 to 10,000 for younger adults. The data are observational, from a single week of step counting, mostly with waist-worn research devices.
The Lancet Public Health
Accelerometers on 36,383 adults: any activity, even light, linked to lower mortality
In eight pooled cohorts (36,383 adults, mean age 62.6 years, 2,149 deaths over a median 5.8 years), the most active quarter by accelerometer-measured total activity had a mortality hazard ratio of 0.27 (95% CI 0.23 to 0.32) against the least active, and the most sedentary quarter had 2.63 (1.94 to 3.56). Light activity alone showed the same pattern, with 0.38 (0.28 to 0.51) in the top quarter. These are observational associations in adults aged 40 and over from the US and western Europe, so illness-driven inactivity and confounding cannot be excluded.
BMJ

